pubmed.ncbi.nlm.nih.gov

Baseline quality of life factors predict long term survival after elective resection for colorectal cancer - PubMed

Baseline quality of life factors predict long term survival after elective resection for colorectal cancer

Abhiram Sharma et al. Int J Surg Oncol. 2013.

Abstract

Background: Studies have shown an association between baseline quality of life (Qol) and survival in advanced cancers. The aim of this study was to investigate their predictive value in long term survival after elective colorectal cancer resection.

Methods: A consecutive series of patients undergoing elective colorectal cancer surgery for nonmetastatic disease were recruited in 2003/04. Patients completed standardized quality of life questionnaires (HADS, FACTC, MRS, and PANAS) prior to and 6 weeks after surgery. Univariate (log-rank test) and multivariate analyses (Cox proportional hazards) were performed to predict long term survival.

Results: Ninety-seven patients met the inclusion criteria. Sixty-five (67%) were male and the median age of the group was 70 years. Forty-six (47.5%) patients had died and the mean survival was 1,741 days (median 2159, range 9-2923 days). Preoperative mood rating scale and functional assessment of cancer therapy-colorectal FACT C emotional well-being and postoperative FACT C additional concerns were independent predictors of long term survival.

Conclusion: Incorporating psychosocial measures in preoperative assessment of cancer patients could help to identify patients who require assessment with a view to implementing psychosocial interventions. These active interventions to maximize mood and well-being should form an integral part of multidisciplinary treatment in these patients.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lipscomb J, Gotay CC, Snyder C. Outcomes Assessment in Cancer. Cambridge, Mass, USA: Cambridge University Press; 2005.
    1. Gotay CC, Kawamoto CT, Bottomley A, Efficace F. The prognostic significance of patient-reported outcomes in cancer clinical trials. Journal of Clinical Oncology. 2008;26(8):1355–1363. - PubMed
    1. Quinten C, Coens C, Mauer M, et al. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. The Lancet Oncology. 2009;10(9):865–871. - PubMed
    1. Efficace F, Osoba D, Gotay C, Sprangers M, Coens C, Bottomley A. Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Annals of Oncology. 2007;18(4):775–781. - PubMed
    1. Coates A, Gebski V, Bishop JF, et al. Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. The New England Journal of Medicine. 1987;317(24):1490–1495. - PubMed

MeSH terms